|
|
|
|
| LEADER |
01372cam a2200349Ia 4500 |
| 001 |
in00002543631 |
| 005 |
20211202192557.0 |
| 006 |
m d f |
| 007 |
cr an||||||||| |
| 008 |
091204s1987 mdu s f000 0 eng d |
| 035 |
|
|
|a (OCoLC)ocn472608789
|
| 040 |
|
|
|a GPO
|c GPO
|d MvI
|d UtOrBLW
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a WWW
|
| 074 |
|
|
|a 0475 (online)
|
| 086 |
0 |
|
|a HE 20.4002:SA 4
|
| 245 |
0 |
0 |
|a Guidelines for submitting samples and analytical data for methods validation.
|
| 246 |
1 |
|
|i At head of title:
|a Drugs
|
| 264 |
|
1 |
|a Rockville, Md. :
|b Food and Drug Administration, Center for Drugs and Biologics, Office of Drug Research and Review,
|c [1987]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a "February 1987."
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Drug approval
|z United States.
|
| 650 |
|
0 |
|a Drugs
|x Analysis
|x Government policy
|z United States.
|
| 776 |
0 |
8 |
|i Print version:
|t Guidelines for submitting samples and analytical data for methods validation
|w (OCoLC)70390499
|
| 710 |
2 |
|
|a Center for Drugs and Biologics (U.S.).
|b Office of Drug Research and Review.
|
| 856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/LPS117249
|t 0
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 18f379e3-b11d-3252-a40d-7b14eac32b9f
|i 8680a07e-f759-3256-8960-cff131bb6697
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e HE 20.4002:SA 4
|h Superintendent of Documents classification
|
| 998 |
f |
f |
|a HE 20.4002:SA 4
|t 0
|l Available Online
|